Clopidogrel Bisulphate 75mg + Aspirin 150mg is a dual antiplatelet therapy formulated to prevent harmful blood clot formation in patients at risk of cardiovascular events. This combination works synergistically to reduce platelet aggregation and lower the risk of heart attack, stroke, and other thrombotic complications. Clopidogrel inhibits ADP-mediated platelet activation, thereby preventing platelets from sticking together. Aspirin inhibits cyclooxygenase (COX-1), reducing thromboxane A2 production and further decreasing clot formation. This combination is commonly prescribed after angioplasty, stent placement, acute coronary syndrome, and in patients with established cardiovascular disease. It provides comprehensive cardiovascular protection and helps improve long-term clinical outcomes.
